Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02834741 · ClinicalTrials.gov registry record · Phase 1
Safety, Tolerability, PK of Oral NYX-2925 in Healthy Volunteers
A Phase 1 study, sponsored by Aptinyx.
- Completed
- Registry status
- Phase 1
- Development phase
- 84
- Enrollment target
NCT02834741: Completed Phase 1 study, sponsored by Aptinyx.
NCT02834741 is a Phase 1 study that has completed, run by Aptinyx. The registered enrollment target is 84 participants, above the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (40% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02834741, a Phase 1 study, has completed, sponsored by Aptinyx.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 84 participants
- Enrollment target
Study Summary
This is a first in human study of NYX-2925. It will evaluate single and multiple ascending doses of NYX-2925 in healthy volunteers.
Interventions
- DRUG NYX-2925
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 84 participants |
| Start Date | 2016-07 |
| Est. Completion | 2017-03 |
| Phase | Phase 1 |
What the finished NCT02834741 record still lists
NCT02834741 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 84 participants, a relatively small participant target, above the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (40% higher).
The record links to 0 conditions, and to 1 intervention - of which NYX-2925 is the first listed.
NCT02834741 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02834741 about?
NCT02834741 is a clinical study titled "Safety, Tolerability, PK of Oral NYX-2925 in Healthy Volunteers". This is a first in human study of NYX-2925. It will evaluate single and multiple ascending doses of NYX-2925 in healthy volunteers.
What is the current status of trial NCT02834741?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 84 participants. The study started on 2016-07. Estimated completion is 2017-03.
What interventions are being tested in trial NCT02834741?
The interventions under investigation include: NYX-2925 (DRUG).
Who is sponsoring clinical trial NCT02834741?
This trial is sponsored by Aptinyx, which has 8 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02834741's enrollment target sits among peer trials
84 659th of 2000 higher than 1,336 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02391519 · 84 participants
Effects of High Altitude on AMPK Activation
- NCT03838536 · 84 participants · NA
Synergistic Activity of Human Milk Nutrients and Infant Cognition
- NCT03884075 · 84 participants · Phase 2
Non-Alcoholic Fatty Liver Disease, the HEpatic Response to Oral Glucose, and the Effect of Semaglutide (NAFLD HEROES)
- NCT03894917 · 84 participants
Characterizing Disease Biology, Treatment and Toxicity in Older Adults With Hepatocellular Carcinoma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia